ANI Pharmaceuticals, Inc. (ANIP)
Drug Manufacturers - Specialty & Generic · Healthcare · $1.9B
Intrinsic Value (Consensus)
$65.23
Current Price
$81.68
Margin of Safety
-20.1%
20.1% Above Intrinsic Value
Value: $65
Price: $82
Valuation Model Estimates
Current Price: $81.68
DCF (Discounted Cash Flow)
$119.90
Graham Number
$42.38
Earnings Power Value
$32.23
Relative Value (P/E)
$66.40
Dividend Discount Model
Not applicable
—
Consensus Value
$65.23
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $3.32
- EPS (Forward)
- $3.49
- Book Value
- $24.04
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 14.5%
- Debt/Equity
- 24%
- Revenue Growth
- 43.8%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 0.44
Data last updated: 2026-06-12
Source: Yahoo Finance